MD News and Press, Mednax Inc. From 02/17/22

MEDNAX, Inc. (MD) Q4 2021 Earnings Conference Call February 17, 2022, 9:00 AM ET Company Participants Mark Ordan – Chief Executive Officer Marc Richards – Chief Financial Officer Jim Swift – Chief Development Officer Charles Lynch – Senior Vice President, Finance &...

Mednax, Inc. (NYSE: MD) today announced that it will present on Friday, February 18, 2022 at 8:40 a.m. ET to investors attending SVB Leerink’s 11 th Annual Global Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts. ...

Mednax press release (NYSE:MD): Q4 Non-GAAP EPS of $0.52 beats by $0.09. Revenue of $499M (+19.7% Y/Y) beats by $16.5M. On a preliminary basis, Mednax anticipates that its 2022 Adjusted EBITDA, as defined above, will be at least $270 million. For further details see: Mednax Non-GAAP EPS...

Mednax (NYSE:MD) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open. The consensus EPS Estimate is $0.43 (+72.0% Y/Y) and the consensus Revenue Estimate is $482.5M (+15.7% Y/Y). Over the last 2 years, MD has beaten EPS estimates 63% of the time and has...

Carlyle Group (CG -0.6%) has named Linda Hefner Filler, a former Walgreen (NASDAQ:WBA) executive, and Mednax (NYSE:MD) CEO Mark Ordan to its board, effective April 1, 2022. Meanwhile, Janet Hill retired from the board after a decade of service. The two new addition and the retirement will inc...

Redeems 6.25% Senior Notes Due 2027 Mednax, Inc. (NYSE: MD) (“Mednax”) announced today that on February 11, 2022 it closed the previously announced issuance of $400.0 million aggregate principal amount of unsecured 5.375% Senior Notes due 2030 (the “ N...

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, February 17, 2022 at 9:00 a.m. ET, to discuss results from operations for the quarter and the year ended December 31, 2021. A detailed press release will be issued the morning of February 17, 2022 bef...

Mednax, Inc. (NYSE: MD) and its affiliated practices operating as Pediatrix® Medical Group (Pediatrix), the nation’s leading provider of highly specialized health care for women, children and babies, today announced the acquisition of Night Lite Pediatrics, LLC (Night Lite O...

Mednax (NYSE:MD) priced its $400M of 5.375% Senior Notes due 2030 in a private offering. Net proceeds, including cash on hand and proceeds from its credit agreement will be used to redeem outstanding 6.25% Senior Notes due 2027. Closing date is February 11, 2022. Previously (Feb. 1)...

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today the pricing of $400.0 million aggregate principal amount of 5.375% Senior Notes due 2030 (the “ Notes ”) in a private offering (the “ Offering ”) that is exempt from the registration req...